Four Monday Launches Sets Stage for Healthcare-Heavy Week

The market may be “pulling back”…but healthcare and biotech IPOs keep moving forward.

The third full week of June will have four five IPOs scheduled to price this week.

The week begins with Royalty Pharmaceuticals (RPRX) pricing Monday after the close for a Tuesday debut. At the high-end of the $25-$28 range, Royalty Pharmaceuticals would raise $1.96bn which would make it the largest cash raise of 2020 behind Warner Music Group (WMG).

IPO Boutique received a message regarding color of the RPRX offering complete with our commentary on how we believe the deal will open and is available for paying subscribers.

As for the three launches on Monday, Forma Therapeutics (FMTX), Repare Therapeutics (RPTX) & Progenity Inc (PROG)…they will all price Thursday evening for a Friday debut.

Update: A fourth IPO launched Monday morning — Genetron Holdings (GTH)

Company: Progenity, Inc.
Symbol: PROG
Description: They are a biotechnology company with an established track record of success in developing and commercializing molecular testing products as well as innovating in the field of precision medicine.
Shares: 6.66 million
Price Range: $14.00-$16.00
Market Cap: $632m-$722m
Trade Date: Friday, 6/19
Underwriter(s): Piper Sandler, Wells Fargo
Co-Manager(s): Baird, Raymond James, BTIG
Terms Added: 6-15-20

Company: Forma Therapeutics Inc.
Symbol: FMTX
Description: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Shares: 11.76 million
Price Range: $16.00-$18.00
Market Cap: $588m-$662m
Trade Date: Friday, 6/19
Underwriter(s): Jefferies, SVB Leerink, Credit Suisse
Terms Added: 6-15-20

Company: Repare Therapeutics Inc.
Symbol: RPTX
Description: They are a leading precision oncology company enabled by our proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Synthetic lethality, or SL, represents a clinically validated approach to drug development.
Shares: 7.35 million
Price Range: $16.00-$18.00
Market Cap: $504m-$567m
Trade Date: Friday, 6/19
Underwriter(s): Morgan Stanley, Goldman Sachs, Cowen, Piper Sandler
Terms Added: 6-15-20

For color, commentary and ratings on these IPO, please consider signing up for  an IPO Boutique subscription. We pride ourselves in obtaining the necessary information needed for regular syndicate players to put them in a winning position at first trade.

UPDATE: Genetron Holdings updated terms for its #IPO and will also debut on Friday.

Company: Genetron Holdings Limited
Symbol: GTH
Description: They are a leading and fast-growing precision oncology company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment.
Shares: 13 million ADSs
Price Range: $11.50-$13.50
Trade Date: Friday, 6/19
Underwriter(s): Credit Suisse, CICC
Co-Manager(s): BTIG, Canaccord Genuity
Terms Added: 6-15-20